Reverie Mind has acquired the Arizona Ketamine Treatment and Research Institute.
Located in the Arizona State University Research Park in Tempe, Arizona, Ketamine Treatment and Research Institute (AKTARI) provides ketamine treatment for depression, bipolar disorder, OCD, anxiety, PTSD, panic disorder, alcohol abuse and opiate addiction.
Reverie Mind, also based in Tempe, Arizona, is a psychedelic clinic and research organization for mental wellness services and coordinated clinical trials. Reverie’s clinics are designed to provide qualified individuals access to plant-based therapies, special access programs, traditional therapy options and clinical trials focused on psychedelic treatments for mental wellness and pain management.
Terms of the deal were not disclosed.
According to the LevinPro HC database, this was the 25th infusion services transaction of 2022. This compares with 10 infusion services deals recorded between January 1, 2021, and November 18, 2021.
